Market access in regenerative medicines: an interview with Tingting Qiu

In this interview, we speak to Tingting Qiu of Aix-Marseille University (Marseille, France) about market access in the world of regenerative medicine (RM). Following publication in the journal Regenerative Medicine, Tingting dives deep into how RMs have been assessed with just standards by health technology assessment (HTA) bodies, or whether stakeholders need to change their perspective on these transformational treatments. Please could you introduce yourself, your organization(s) and provide a brief summary of your career to date? I am Tingting Qiu. I got my PhD at the Aix-Marseille University, which focused on market access of innovative cell and gene therapies,...